Viewing Study NCT03992456


Ignite Creation Date: 2025-12-24 @ 11:38 PM
Ignite Modification Date: 2026-01-24 @ 11:53 PM
Study NCT ID: NCT03992456
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-21
First Post: 2019-06-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer
Sponsor: Academic and Community Cancer Research United
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colon Adenocarcinoma View
None Metastatic Colorectal Carcinoma View
None Metastatic Rectal Adenocarcinoma View
None Stage III Colon Cancer AJCC v8 View
None Stage III Colorectal Cancer AJCC v8 View
None Stage III Rectal Cancer AJCC v8 View
None Stage IIIA Colon Cancer AJCC v8 View
None Stage IIIA Colorectal Cancer AJCC v8 View
None Stage IIIA Rectal Cancer AJCC v8 View
None Stage IIIB Colon Cancer AJCC v8 View
None Stage IIIB Colorectal Cancer AJCC v8 View
None Stage IIIB Rectal Cancer AJCC v8 View
None Stage IIIC Colon Cancer AJCC v8 View
None Stage IIIC Colorectal Cancer AJCC v8 View
None Stage IIIC Rectal Cancer AJCC v8 View
None Stage IV Colon Cancer AJCC v8 View
None Stage IV Colorectal Cancer AJCC v8 View
None Stage IV Rectal Cancer AJCC v8 View
None Stage IVA Colon Cancer AJCC v8 View
None Stage IVA Colorectal Cancer AJCC v8 View
None Stage IVA Rectal Cancer AJCC v8 View
None Stage IVB Colon Cancer AJCC v8 View
None Stage IVB Colorectal Cancer AJCC v8 View
None Stage IVB Rectal Cancer AJCC v8 View
None Stage IVC Colon Cancer AJCC v8 View
None Stage IVC Colorectal Cancer AJCC v8 View
None Stage IVC Rectal Cancer AJCC v8 View
None Unresectable Colon Adenocarcinoma View
None Unresectable Colorectal Carcinoma View
None Unresectable Rectal Adenocarcinoma View
Keywords: